This is FDA related issue, anything they disclose should be made public earlier.
If they don't announce anything that implies they are still in talks with FDA and probably the investigation is still on. it is Takeda's interest to bring the product to the market place quicker and achieve reasonable sales volume.
I'm unmoved with any of these cockroaches rattling. For me Takeda will not abandon a 2 BLN $ revenue blockbuster/approved drug and walk away, I'll stick with this theory.
Takeda need not walk away from O for AFFY to go BK. All Takeda needs to do is stand around for a little while longer and AFFY will go BK all on its own. Then Takeda can buy out the $180M milestone/royalties agreement for pennies on the dollar at a bankruptcy court approved price with no fear of any litigation to challenge fairness. Takeda saves lots of money that would otherwise go to AFFY plaintiff litigants and current AFFY shareholders are left holding an the empty AFFY bag.
according to your theory, takeda is gaining omontys and shareholders holding a BAG Why takeda is waiting since year or working for a ROOT cause..Is it LIE?Ithink you are thinking everybody like yourself...Right..ha ha ha just get the TUMS after the heavy meal...